News tagged with prostate cancers

Inflammation in prostate may reduce cancer risk

Doctors at the North Shore-LIJ Health System have discovered that increased inflammation in the prostate may predict reduced risk for prostate cancer. The findings are published online in Cancer.

Dec 09, 2013
popularity 4 / 5 (1) | comments 0

Enzalutamide in prostate cancer: Hints of added benefit

Enzalutamide (trade name: Xtandi) has been approved since June 2013 for men with metastatic prostate cancer in whom the commonly used hormone blockade is no longer effective and who have already been treated with the cytostatic ...

Dec 06, 2013
popularity not rated yet | comments 0

Prostate cancer biomarker may predict patient outcomes

Researchers at Vanderbilt University Medical Center and the University of Alberta in Canada have identified a biomarker for a cellular switch that accurately predicts which prostate cancer patients are likely ...

Dec 05, 2013
popularity not rated yet | comments 0 | with audio podcast

How prostate cancer cells evolve

(Medical Xpress)—UCLA researchers have discovered how prostate cancer stem cells evolve as the disease progresses, a finding that could help point the way to more highly targeted therapies. 

Dec 04, 2013
popularity 5 / 5 (6) | comments 0 | with audio podcast

Protein in prostate biopsies signals increased cancer risk

Researchers from Weill Cornell Medical College have shown that the presence of a particular protein in biopsied prostate tissue substantially increases the likelihood that cancer will develop in that organ. The discovery ...

Dec 03, 2013
popularity not rated yet | comments 0 | with audio podcast

New biomarkers improve prostate cancer diagnostics

New biomarkers will improve diagnostics of endemic diseases in future, such as prostate cancer. Their mission: to recognize the tumor earlier and classify it more precisely – thereby helping avoid unnecessary ...

Dec 02, 2013
popularity not rated yet | comments 0

World first trial to improve prostate cancer care

Researchers and clinicians from the University of Sydney and the Northern Sydney Cancer Centre are leading a world first clinical trial using a tracking system to improve prostate cancer radiotherapy treatment.

Nov 28, 2013
popularity not rated yet | comments 0

Bayer bids 1.8 bn euro for Norway's Algeta

German pharmaceutical group Bayer has made a bid for its Norwegian partner and competitor Algeta, specialised in cancer treatments, for 1.8 billion euro ($2.4 billion), the Nordic company said Tuesday.

Nov 26, 2013
popularity not rated yet | comments 0